Alex Sirois

Alex Sirois

About Alex Sirois

“Alex Sirois is a freelance contributor to InvestorPlace who writes to give you investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

Outside of investments, his interests include anything outdoor or health related, as well as music and other creative outlets. Originally from Maine, he has lived all over the U.S. and currently lives in Korea.”

Recent Articles

Coupang May Be Out of Favor, but It Isn’t Out for Long

CPNG stock truly looks attractive at these prices meaning it is a contrarian pick worth considering at its discounted levels.

Lucid Looks Like a Long-term Winner and a Buy

LCID stock is a preeminent name in a new round of electric vehicle (EV) entrants. It will chip away at Tesla, making it worth your while.

Harvest Finance Offers Yield Farming (For Some) But Volatility (To All)

Harvest Finance is a good introduction to the risky practice of yield farming. Learn more here if you're a risk tolerant, crypto enthusiast.

Matterport Just Became Much More Interesting Due to Enview

MTTR stock should rise if the market appreciates its strategy in acquiring Enview. It's logical and seems accretive so investors should watch out.

Allakos Is a Cautionary Tale of Biopharmaceutical Investing

ALLK stock dropped off a cliff following disappointing study results, which illustrates what can go wrong in risky biopharma equities.